|
Originally published In Press as doi:10.1074/jbc.M105785200 on July 30, 2001
J. Biol. Chem., Vol. 276, Issue 39, 36535-36542, September 28, 2001
PDZ Interaction Sites in Integrin Subunits
TIP-2/GIPC BINDS TO A TYPE I RECOGNITION SEQUENCE IN
6A/ 5 AND A NOVEL SEQUENCE IN
6B*
Taneli T.
Tani and
Arthur M.
Mercurio
From the Division of Cancer Biology and Angiogenesis, Department of
Pathology, Beth Israel Deaconess Medical Center and Harvard Medical
School, Boston, Massachusetts 02215
We used published peptide library data to
identify PDZ recognition sequences in integrin subunit cytoplasmic
domains and found that the 6A and 5
subunits contain a type I PDZ binding site (TSDA*) (asterisk indicates
the stop codon). The 6A cytoplasmic domain was
used for screening a two-hybrid library to find interacting proteins.
The bulk of the captured cDNAs (60%) coded for TIP-2/GIPC, a cytoplasmic protein with one PDZ domain. The interaction of TIP-2/GIPC with different integrin subunits was tested in two-hybrid and in vitro binding assays. Surprisingly, TIP-2/GIPC bound
strongly to the C terminus of both 6A and
6B, although the 6B sequence (ESYS*) is
not suggestive of a PDZ binding site because of its polar C-terminal
residue. For high affinity interaction with TIP-2/GIPC, at least one of
the residues at positions -1 and -3 must be negatively charged. An
aliphatic residue at position 0 increases the affinity of but is not
required for this interaction. The 5 integrin subunit also bound to TIP-2/GIPC. The 6 integrin and TIP-2/GIPC
co-localize in retraction fibers in carcinoma cells plated on laminin,
a finding suggesting a functional interaction in vivo. Our
results demonstrate that both splice variants of 6
integrin contain a conserved PDZ binding site that enables interaction
with TIP-2/GIPC. The binding site in 6B defines a
new subclass of type I PDZ interaction site, characterized by a
non-aliphatic residue at position 0.
*
This work was supported by United States Army Medical
Research and Materiel Command Grant DAMD17-00-1-0155, the Academy of Finland, and the Finnish Cultural Foundation (to T. T. T.) and by
National Institutes of Health Grants AI39264 and CA80789 (to A. M. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of
Cancer Biology and Angiogenesis, Dept. of Pathology, Beth Israel
Deaconess Medical Center and Harvard Medical School, 330 Brookline
Ave., Boston, MA 02215. Tel.: 617-667-7714; Fax: 617-975-5531; E-mail: amercuri@caregroup.harvard.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. H. Muders, P. K. Vohra, S. K. Dutta, E. Wang, Y. Ikeda, L. Wang, D. G. Udugamasooriya, A. Memic, C. N. Rupashinghe, G. B. Baretton, et al.
Targeting GIPC/Synectin in Pancreatic Cancer Inhibits Tumor Growth
Clin. Cancer Res.,
June 15, 2009;
15(12):
4095 - 4103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Lanahan, T. W. Chittenden, E. Mulvihill, K. Smith, S. Schwartz, and M. Simons
Synectin-dependent gene expression in endothelial cells
Physiol Genomics,
November 21, 2006;
27(3):
380 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, M. O'Donnell, A. D. Gitler, and P. S. Klein
Kermit 2/XGIPC, an IGF1 receptor interacting protein, is required for IGF signaling in Xenopus eye development
Development,
September 15, 2006;
133(18):
3651 - 3660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Reed, C. Cefalu, B. H. Bellaire, J. A. Cardelli, T. Louis, J. Salamon, M. A. Bloecher, and R. C. Bunn
GLUT1CBP(TIP2/GIPC1) Interactions with GLUT1 and Myosin VI: Evidence Supporting an Adapter Function for GLUT1CBP
Mol. Biol. Cell,
September 1, 2005;
16(9):
4183 - 4201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Favre-Bonvin, C. Reynaud, C. Kretz-Remy, and P. Jalinot
Human Papillomavirus Type 18 E6 Protein Binds the Cellular PDZ Protein TIP-2/GIPC, Which Is Involved in Transforming Growth Factor {beta} Signaling and Triggers Its Degradation by the Proteasome
J. Virol.,
April 1, 2005;
79(7):
4229 - 4237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Bohlson, M. Zhang, C. E. Ortiz, and A. J. Tenner
CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis
J. Leukoc. Biol.,
January 1, 2005;
77(1):
80 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brown, T. Muth, and M. Caplan
The COOH-terminal tail of the GAT-2 GABA transporter contains a novel motif that plays a role in basolateral targeting
Am J Physiol Cell Physiol,
May 1, 2004;
286(5):
C1071 - C1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hirakawa, C. Galet, M. Kishi, and M. Ascoli
GIPC Binds to the Human Lutropin Receptor (hLHR) through an Unusual PDZ Domain Binding Motif, and It Regulates the Sorting of the Internalized Human Choriogonadotropin and the Density of Cell Surface hLHR
J. Biol. Chem.,
December 5, 2003;
278(49):
49348 - 49357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hasson
Myosin VI: two distinct roles in endocytosis
J. Cell Sci.,
September 1, 2003;
116(17):
3453 - 3461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Hu, W. Chen, N. P. Martin, E. J. Whalen, R. T. Premont, and R. J. Lefkowitz
GIPC Interacts with the {beta}1-Adrenergic Receptor and Regulates {beta}1-Adrenergic Receptor-mediated ERK Activation
J. Biol. Chem.,
July 3, 2003;
278(28):
26295 - 26301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nawrotzki, M. Willem, N. Miosge, H. Brinkmeier, and U. Mayer
Defective integrin switch and matrix composition at alpha 7-deficient myotendinous junctions precede the onset of muscular dystrophy in mice
Hum. Mol. Genet.,
March 1, 2003;
12(5):
483 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Blobe, X. Liu, S. J. Fang, T. How, and H. F. Lodish
A Novel Mechanism for Regulating Transforming Growth Factor beta (TGF-beta ) Signaling. FUNCTIONAL MODULATION OF TYPE III TGF-beta RECEPTOR EXPRESSION THROUGH INTERACTION WITH THE PDZ DOMAIN PROTEIN, GIPC
J. Biol. Chem.,
October 19, 2001;
276(43):
39608 - 39617.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|